Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$521.76M
Total Bought:
$132.07M
Total Sold:
$44.36M
Net Transaction:
+$87.71M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620$196.98M$134.02M25.69%-$62.97M
Disc Medicine, Inc.(IRON)2,509,4562,384,456-125,000$159.10M$118.36M22.69%-$40.74M
Dyne Therapeutics, Inc.(DYN)8,019,3549,130,465+1,111,111$188.94M$95.50M18.30%-$93.43M
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,2570$81.47M$50.99M9.77%-$30.48M
Sionna Therapeutics, Inc.(SION)03,694,020+3,694,020$0$38.64M7.41%+$38.64M
Third Harmonic Bio, Inc.10,402,28610,402,2860$107.04M$36.10M6.92%-$70.94M
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$43.29M$19.80M3.79%-$23.49M
Vigil Neuroscience, Inc.5,836,8745,836,8740$9.92M$10.39M1.99%+$466.9K
Ikena Oncology, Inc.5,018,1785,018,1780$8.23M$6.42M1.23%-$1.81M
Aerovate Therapeutics, Inc.1,799,2321,799,2320$4.77M$4.52M0.87%-$251.9K
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$7.20M$3.45M0.66%-$3.74M
Generation Bio, Co.8,279,4848,279,4840$8.78M$3.35M0.64%-$5.42M
Spero Therapeutics, Inc.(SPRO)305,255305,2550$314.4K$219.8K0.04%-$94.6K
Tectonic Therapeutic, Inc.(TECX)78,4470-78,447$3.62M$0—-$3.62M
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q1 2025 | TickerTrail